Breakthrough miniaturized brain-machine interface enables brain-to-text communication

DENVER — In women with type 2 diabetes, use of GLP-1 receptor agonists was associated with a reduced risk of new-onset uterine fibroids compared with

Boston Phar­ma­ceu­ti­cals suc­ceed­ed on two close­ly watched ef­fi­ca­cy end­points for its Phase 2 MASH study, putting the com­pa­ny in con­tention with oth­er biotechs seek­ing to